<DOC>
	<DOCNO>NCT02310074</DOCNO>
	<brief_summary>Idiopathic hypogonadotropic hypogonadism ( IHH ) common disorder sex development ( DSD ) .Therapy IHH include hormone replacement therapy , gonadotropin therapy pulse infusion gonadotropin release hormone ( GnRH ) .In present study , compare different efficacy safety pulsatile GnRH pump therapy combination gonadotropin therapy fertility sexual development male patient IHH .</brief_summary>
	<brief_title>Efficacy Safety Pulsatile Gonadotropin Releasing Hormone Pump Treatment Patients With Idiopathic Hypogonadotropic Hypogonadism</brief_title>
	<detailed_description>Idiopathic hypogonadotropic hypogonadism ( IHH ) common disorder sex development ( DSD ) .Therapy IHH include hormone replacement therapy , gonadotropin therapy pulse infusion gonadotropin release hormone ( GnRH ) .In present study , compare different efficacy safety pulsatile GnRH pump therapy combination gonadotropin therapy fertility sexual development male patient IHH . The primary endpoint achievement pregnancy female partner . Secondary endpoint time actual attainment various sperm threshold : sperm concentration &gt; 0*10^6/ml , &gt; 1.0 *10^6/ml &gt; 15 *10^6/ml , respectively . The clinical laboratory characteristic include testicular prostatic volume , Tanner stage pubic hair genital , serum hormone level [ especially serum testosterone , luteinizing hormone ( LH ) , Follicle-Stimulating Hormone ( FSH ) level ] , sperm concentration per ejaculate , adverse event baseline end treatment also evaluate .</detailed_description>
	<mesh_term>Hypogonadism</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<criteria>1 . Age great 16 yr 2 . Diagnosed idiopathic hypogonadotropic hypogonadism clinical sign symptom hypogonadism 3 . Hypogonadal serum testosterone level ( &lt; 166ng/dl ) presence low normal gonadotropin 4 . Normal level anterior pituitary hormone 5 . Normal MRI scan hypothalamopituitary region 6 . Had discontinue prior treatment ( testosterone gonadotropin therapy ) least three month enrollment 1 . With significant medical condition ( include malignant disease ) , laboratory abnormality , psychiatric disorder prevent subject participate study 2 . Congenital hypopituitarism 3 . Any medical surgical condition possibly affect experiment result 4 . Any clinically significant allergic disease allergic study drug 5 . Recently drug alcohol abuse ( &gt; 35unit/week,1unit=8 g alcohol @ 1 standard drink @ 250ml beer @ 140ml wine @ 25ml strong alcohol drink like whiskey . )</criteria>
	<gender>Male</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>